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Fluorescence detection of GDP in real time with the reagentless biosensor
rhodamine–ParM
Simone KUNZELMANN and Martin R. WEBB1
MRC National Institute for Medical Research, Mill Hill, London NW7 1AA, U.K.
The development of novel ﬂuorescence methods for the detection
of key biomolecules is of great interest, both in basic research
and in drug discovery. Particularly relevant and widespread
molecules in cells are ADP and GDP, which are the products
of a large number of cellular reactions, including reactions
catalysed by nucleoside triphosphatases and kinases. Previously,
biosensors for ADP were developed in this laboratory, based
on ﬂuorophore adducts with the bacterial actin homologue
ParM. It is shown in the present study that one of these
biosensors, tetramethylrhodamine–ParM, can also monitor GDP.
The biosensor can be used to measure micromolar concentrations
of GDP on the background of millimolar concentrations of
GTP. The ﬂuorescence response of the biosensor is fast, the
response time being <0.2 s. Thus the biosensor allows real-time
measurements of GTPase and GTP-dependent kinase reactions.
Applications of the GDP biosensor are exempliﬁed with two
different GTPases, measuring the rates of GTP hydrolysis and
nucleotide exchange.
Key words: ﬂuorescence, GTPase, nucleotide-exchange factor,
rhodamine stacking, sensor.
INTRODUCTION
GTPases play essential roles in many cellular processes
such as signal transduction, cytoskeletal reorganization, vesicle
trafﬁcking, regulation of translation, membrane remodelling and
pathogen defence [1–3]. Typically the function of GTPases
relies on cycling between different protein conformations,
determined by the state of the bound nucleotide, either GDP
or GTP. Switching between these active and inactive states is
tightly controlled by regulatory proteins that affect the rates
of exchange of bound nucleotide (GDP to GTP) and GTP
hydrolysis to GDP and Pi. Mutations in GTPases or their
regulators that interfere with the GTPase cycle cause a number of
human diseases, an example being the frequent involvement
of Ras-related GTPases in human cancer [4]. Assays to measure
the activity of GTPases are therefore of great interest for basic
research as well as drug discovery.
Fluorescentreagentlessbiosensorsarewidelyusedtoolsforthe
detection and quantitative measurement of biologically important
moleculesandhenceforreportingbiologicalactivity.Theyconsist
of a biomolecule (protein, DNA and RNA) that speciﬁcally binds
the analyte and a ﬂuorescent reporter group that couples the
recognition of that analyte to a ﬂuorescence change. Protein-
based biosensors are a subgroup of reagentless biosensors, where
the recognition unit is a ﬂuorescently labelled protein or protein
domain. Examples include biosensors for Pi, sugars, amino acids,
cations such as Ca
2+, nucleotides and single-stranded DNA [5–
10].Thesetypesofbiosensorsofferanumberofadvantages.First,
the signal change can be very fast, limited only by the speed of
ligand binding to the protein or the associated conformational
change. Hence they can be used for real-time measurements
of enzyme activity. Secondly, the protein–ligand interaction can
provide high speciﬁcity. Finally, a key feature of reagentless
biosensors is that only a single component, the labelled protein,
is needed for detection, thereby minimizing interference with the
system under study.
Fluorescent biosensors for ADP were previously developed
by engineering ParM, an actin homologue from bacteria that
is involved in plasmid segregation [11,12]. The design of the
biosensor relies on a large conformational change of ParM that
occurs on nucleotide binding: the two subdomains of the actin-
fold rotate against each other by 25◦, thereby closing the
nucleotide-binding site located in a cleft between them [13]. This
conformational change was coupled to an optical signal ﬁrst by
introducing cysteine residues at speciﬁc locations near the rim of
the binding cleft. These cysteine residues provide speciﬁc sites to
couplewiththiol-reactiveprobes(maleimidesoriodoacetamides)
[14]. The ﬂuorophores were placed such that their ﬂuorescence
responds to the conformation change on ADP binding. Two
distinct versions with different properties were produced using
eitheracoumarin,MDCC[11],oratetramethylrhodamine[12]as
thereporter.Thecoumarinversionmakesuseoftheenvironmental
sensitivity of the signal of the single ﬂuorophore.
In contrast, the rhodamine version is achieved by labelling
two cysteine residues of a ParM mutant with either 5- or 6-IATR
(iodoacetamidotetramethylrhodamine)(SupplementaryFigureS1
athttp://www.BiochemJ.org/bj/440/bj4400043add.htm). Thetwo
labelling sites are located on the two different subdomains,
either side of the binding cleft. In the nucleotide-free state
the two rhodamines are in close proximity and are likely
to form a stacking interaction that largely quenches their
ﬂuorescence [15]. Nucleotide binding causes an increase
in ﬂuorescence, probably by disturbing the stacking interaction
of the rhodamines. In addition to introducing the cysteine
residues for label attachment, other mutations were introduced to
enhance discrimination against nucleoside triphosphate binding
and prevent the ParM polymerizing, so it remains a monomer
[11,12]. The ﬁnal protein used for this rhodamine-labelled
biosensor is (His6/K33A/D63C/T174A/T175N/D224C/C287A)
ParM [12]. It is demonstrated in the present study that the
tetramethylrhodamine-labelled ParM is also suitable for the dete-
ction of other nucleoside diphosphates, including GDP, thus
Abbreviations used: DTT, dithiothreitol; ESI, electrospray ionization; GEF, guanine-nucleotide-exchange factor; hGBP5, human guanylate-binding
protein 5; IATR, iodoacetamidotetramethylrhodamine; Sos, Son of Sevenless; Soscat, catalytic domain of Sos; TCEP, tris(2-carboxyethyl)phosphine.
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providing a novel method to measure the activity of GTPases and
other enzymes that produce GDP. The biosensor is characterized
for its interaction with guanine and other nucleotides. Example
assays demonstrate the use of the biosensor to assay GDP release
by enzymes following GTP hydrolysis or due to nucleotide
exchange.
EXPERIMENTAL
ParM expression, puriﬁcation and labelling with IATR
The ParM construct for rhodamine labelling, ParM (His6/K33A/
D63C/T174A/T175N/D224C/C287A), was generated from
vector pJSC1 containing wild-type ParM [16] by site-directed
mutagenesis (Stratagene) [12]. The identity of the construct was
veriﬁed by DNA sequencing. The protein construct comprised
full-lengthParM(aminoacids1–320)plusanadditional10amino
acid peptide (QSGSHHHHHH) at the C-terminus. Expression
was performed in BL21-Ai cells (Invitrogen) as described
previously [12]. ParM expression cultures were grown at 30◦C
in 2×TY medium containing 100 μg·ml
−1 ampicillin until the
attenuance at 600 nm was 0.4–0.6 cm
−1, when overexpression
was then induced by the addition of 2 mg·l
−1 arabinose. Cells
were harvested after 16 h of induction, resuspended in lysis
buffer {30 mM Tris/HCl (pH 8.0), 25 mM KCl, 1 mM TCEP
[tris(2-carboxyethyl)phosphine] and 0.1% Triton X-100} and
stored at −80◦C. His-tagged ParM was then puriﬁed by Ni-
chelatechromatography.Clearedcellextractsweresupplemented
with 500 mM NaCl and ﬁltered through a 0.45 μm syringe ﬁlter
(Sartorius).Thelysatewasloadedontoa5 mlHisTrapHPcolumn
(GE Healthcare), equilibrated with buffer A [30 mM Tris/HCl
(pH 8.0), 500 mM NaCl and 1 mM TCEP]. The column was
washed with buffer A until the absorbance at 280 nm reached
the baseline, followed by 50 ml of buffer B [30 mM Tris/HCl
(pH 8.0), 25 mM KCl and 1 mM TCEP]. ParM was eluted with
a 100 ml linear gradient of 0–250 mM imidazole in buffer B,
adjusted to pH 8.0. Fractions containing ParM were pooled
and 10 mM DTT (dithiothreitol) was added. Protein solutions
were concentrated using a Vivaspin-20 centrifugal concentrator
(Vivascience)andthenfurtherpuriﬁedoveraHiLoadSuperdex75
column (26/60, GE Healthcare) equilibrated in 30 mM Tris/HCl
(pH 7.5), 25 mM KCl, 1 mM EDTA and 5 mM DTT. Fractions
containing monomeric ParM were pooled and concentrated
again as described above. The concentration of ParM mutants
was determined by absorbance measurements using the molar
absorption coefﬁcient 34380 M
−1 ·cm
−1 at 280 nm, calculated
from the primary sequence [17]. Proteins were shock-frozen in
liquid nitrogen and stored at −80◦C.
The ParM construct contains two exposed cysteine residues
(Cys
63 and Cys
224) that are accessible to modiﬁcation with thiol-
reactive iodoacetamide probes. A third cysteine residue in the
construct (Cys
100) is buried in the core of the structure and is not
readilyaccessibletolabelling(seebelow).LabellingofParMwith
5- or 6-IATR [18] was performed as described previously [12].
In brief, DTT was removed from ParM solutions using a PD10
column (GE Healthcare) and ParM was labelled with IATR at a
4-fold molar excess for 90 min at room temperature (21◦C) in
30 mM Tris/HCl (pH 7.5) and 25 mM KCl. The reaction was
stopped by the addition of 2-mercaptoethanesulfonate, which
captures the unreacted IATR. Free ﬂuorophore was removed
on a PD10 column. Labelled ParM was further puriﬁed by
anion-exchange chromatography on a HiTrapQ HP column (GE
Healthcare) using a gradient of 25–200 mM KCl. The protein
was concentrated in an Amicon ultracentrifugal ﬁlter device
(Millipore),shock-frozeninliquidnitrogenandstoredat −80◦C.
Concentrations of tetramethylrhodamine-labelled ParM mutants
were determined from the absorbance spectra using the molar
absorption coefﬁcient of a small molecule thiol adduct of 5-IATR
atitsisosbesticpoint,ε528 =52000M
−1 ·cm
−1 [19].Thelabelling
stoichiometry of two labels per protein molecule was conﬁrmed
by ESI (electrospray ionization)-MS.
Nucleotides
All nucleotides were purchased from Sigma–Aldrich at
the highest purity available. GTP was puriﬁed further
by anion-exchange chromatography and its purity
was analysed by HPLC as described previously [11].
Nucleotide concentrations were determined from their
absorbance spectra in 20 mM Tris/HCl (pH 7.5) using
the molar absorption coefﬁcients ε253 =13700 cm
−1
for guanine, ε259 =15400 cm
−1 for adenine, ε260 =
9900 cm
−1 for uracil, ε260 =6100 cm
−1 for cytosine and
ε260 =8700 cm
−1 for thymidine nucleotides.
Fluorescence titrations
Equilibrium ﬂuorescence measurements were performed using
a Cary Eclipse ﬂuorescence spectrophotometer (Varian). 5- or
6-ATR–ParM (0.5 μM) was titrated with different nucleotides
and the rhodamine ﬂuorescence was recorded at 577 nm after
excitation at 553 nm. Data were analysed by ﬁtting hyperbolic
curves using the program GraFit 5.0. Titrations were performed
in30 mMTris/HCl(pH 7.5),25 mMKCl,3 mMMgCl2 and5 μM
BSA at 20◦C.
Stopped-ﬂow ﬂuorescence experiments
Stopped-ﬂow measurements were performed using a HiTech
SF61 DX2 stopped-ﬂow instrument equipped with a Xe/Hg
lamp (TgK Scientiﬁc). Association kinetics of 5- and 6-
ATR–ParM and GDP were measured under pseudo-ﬁrst-order
conditionswithexcessofGDPoverParM.Tetramethylrhodamine
ﬂuorescence was excited at 546 nm and emission was detected
with a photomultiplier after ﬁltering emitted light through a
570 nm long-pass ﬁlter. Experimental traces were analysed by
single exponential curve ﬁtting using the HiTech software. All
measurements were performed at 20◦Ci n3 0 m MT r i s / H C l
(pH 7.5), 25 mM KCl, 3 mM MgCl2 and 5 μMB S A .
GTP hydrolysis assay
Steady-state kinetics of GTP hydrolysis by hGBP5 (human
guanylate-binding protein 5) a/b [20] were measured in 50 mM
Tris/HCl (pH 8.0), 25 mM KCl, 5 mM MgCl2,2 m MD T T
and 5 μMB S Aa t2 5 ◦C using a Cary Eclipse ﬂuorescence
spectrophotometer (Varian). Different concentrations of GTP (0–
1 mM) and 5-ATR-ParM (0.25 μM ﬁnal concentration) were
incubated in the cuvette at 25◦C and the reaction was started by
theadditionofhGBP5(0.22 μMﬁnalconcentration).Rhodamine
ﬂuorescence was excited at 553 nm and detected at 577 nm.
The ﬂuorescence response of 5-ATR-ParM was calibrated by
titrating ParM with a GDP standard solution in the presence of 0,
0.5 and 1 mM GTP. Data were analysed by linear regression. The
slope of the calibration was dependent on the GTP concentration
present, albeit the difference was small: approximately 10%
difference between 0 and 1 mM GTP. Assuming a linear
relationshipbetweentheslopeofthecalibrationcurveand[GTP],
for each [GTP] used in the assay a slope was calculated by
linear interpolation. These were used to convert the measured
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Figure 1 Afﬁnity of the biosensor for guanine nucleotides
5-ATR–ParM(0.5μM)wastitratedwithGDP(circles)orGTP(squares)undertwodifferentsalt
conditions, 25mM KCl (closed symbols) or 150mM KCl (open symbols), in 30mM Tris/HCl
(pH7.5),3 mMMgCl2 and5μMBSAat20◦C.Rhodamineﬂuorescencewasexcitedat553nm
andemissionwasrecordedat577nm.DissociationconstantsforGDP,obtainedfromhyperbolic
curve ﬁts, are summarized in Table 1.
ﬂuorescence time traces into the time course of GDP formation.
Initial rates were determined by linear ﬁtting to the data points
with less than 10% of the GTP turned over. Michaelis–Menten
plots (initial rate against [GTP]) were generated and analysed by
hyperbolic curve ﬁtting using GraFit 5.0 [21].
Nucleotide-exchange assays
Nucleotide exchange of H-Ras was measured in 20 mM
Hepes (pH 7.4), 150 mM KCl, 5 mM MgCl2,2 m MD T T
and 5 μMB S Aa t2 5 ◦C using a Cary Eclipse ﬂuorescence
spectrophotometer (Varian). GDP-bound Ras (Ras–GDP) and 5-
ATR-ParM (concentrations given in the legend of Figure 4) were
incubated at 25◦C in the cuvette and the exchange reaction was
started by adding 1 mM GTP and/or the catalytic domain of Sos
(Son of Sevenless; residues 564–1049, Sos
cat) [22]. Fluorescence
was recorded at excitation and emission wavelengths of 553 nm
and 577 nm respectively. The biosensor response was calibrated
asdescribedfortheGTPaseassayabove,butusingthecalibration
in the presence of 1 mM GTP for all data to calculate GDP
concentrations from the ﬂuorescence signal. Data points up to
maximally 10% turnover were analysed to obtain initial rates by
linear regression. Initial rates were plotted as a function of Ras–
GDP concentration and hyperbolic curve ﬁtting was performed
with GraFit 5.0 [21].
RESULTS AND DISCUSSION
NativeParM,theproteinscaffoldoftheADPbiosensorsdescribed
previously, binds guanine nucleotides in addition to adenine
nucleotides [23]. The coumarin-labelled biosensor MDCC–ParM
binds GDP, but does not exhibit a ﬂuorescence change [11],
so this version is not suitable for GDP detection. In contrast,
both isomers ofthe tetramethylrhodamine-based biosensor5- and
6-ATR-ParM (His6/K33A/D63C/T174A/T175N/D224C/C287A)
respond to GDP binding with a ∼10-fold increase in ﬂuorescence
(Figure 1 and Table 1). Before describing the application of the
double rhodamine ParM-based biosensor to GDP measurement,
the precise identity of this molecule is considered.
The substitution reactions of iodoacetates and iodoacetamides
are very selective for thiols (such as in cysteine residues)
[14,24–26], although they can also react with methionine,
tyrosine, histidine and lysine residues. This is, in part, due to
Table 1 Afﬁnity and ﬂuorescence change for the binding of different
nucleoside diphosphates to tetramethylrhodamine-labelled ParM
Equilibrium dissociation constants (Kd) and ﬂuorescence changes (F +/F-) upon nucleotide
binding were determined by ﬂuorescence titration as shown in Figure 1. Data were obtained at
20◦C in 30mM Tris/HCl (pH7.5), 3 mM MgCl2,5μM BSA and 25mM KCl or 150mM KCl
where indicated.
5-ATR-ParM 6-ATR-ParM
Nucleotide F +/F- Kd (μM) F +/F- Kd (μM)
GDP 10.6 75.0 9.5 91.2
GDP (150mM KCl) 11.7 45.8 10.1 48.5
ADP* 14.9 30.2 14.5 37.0
ADP (150mM KCl) * 15.2 15.3 12.3 15.8
dGDP 9.0 105 8.7 149
dADP 13.1 27.5 12.2 41.7
CDP 9.5 826 4.8 760
dCDP 10.6 707 7.4 >1000
UDP 11.6 101 7.2 96.4
TDP 14.1 29.0 15.1 45.0
*Values are from [12].
the much larger nucleophilicity of thiol over other available
groups on a protein that could take part in the nucleophilic
substitution reaction [27] (Supplementary Figure S1). Under
conditions of neutral pH, ambient temperature and limited
excess of iodoacetamide over thiols, the reaction with cysteine
is orders of magnitude faster than reaction with any other
amino acid [14,24–29]. The ParM construct described here
(His6/K33A/D63C/T174A/T175N/D224C/C287A) contains two
exposedcysteineresidues(Cys
63 andCys
224)that,accordingtothe
known crystal structures, are accessible to modiﬁcation; indeed,
they were added for that purpose. A third wild-type cysteine in
the construct (Cys
100) is buried in the core of the structure and so
is unlikely to be modiﬁed. MS showed that each molecule of this
construct is labelled with two acetamidotetramethylrhodamine
moieties [12]. In order to conﬁrm that the two labels are
on the two exposed cysteine residues, two mutants were
constructed with only one exposed cysteine present, ParM
(His6/K33A/D63A/T174A/T175N/D224C/C287A) and ParM
(His6/K33A/D63C/T174A/T175N/D224A/C287A), as well as
one mutant where both exposed cysteine residues were removed,
ParM (His6/K33A/D63A/T174A/T175N/D224A/C287A). These
proteins were reacted with 5-IATR under the same conditions as
the biosensor construct and analysed by ESI-MS (Supplementary
Figure S2 at http://www.BiochemJ.org/bj/440/bj4400043add.
htm) and absorbance spectroscopy (Supplementary Figure S3
at http://www.BiochemJ.org/bj/440/bj4400043add.htm). Both
mutants with only one exposed cysteine residue (63A/224C
and 63C/224A) reacted with only one 5-IATR molecule per
protein (Supplementary Table S1 at http://www.BiochemJ.org/
bj/440/bj4400043add.htm). The mutant that had both cysteine
residues removed (63A/224A) showed only a very small fraction
of labelling (∼4% of the protein, Supplementary Figure S3) and
the majority (96%) was unlabelled. Thus the two labels on the
biosensor are on Cys
63 and Cys
224, introduced for this purpose. It
is possible that a small fraction (<5%) of the protein has some
unspeciﬁc labelling on other amino acids, but importantly this is
unlikely to impair the biosensor function.
As previously shown for ADP, 5- and 6-ATR–ParM behave
very similarly to each other with other nucleoside diphosphates
in terms of afﬁnity, kinetics and signal change. Below,
characterization of the 5-isomer is described, and then the
similarities and differences of 6-ATR–ParM are summarized.
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Figure 2 Kinetics of GDP binding to the biosensor
(A)Fluorescencetimecoursesaftermixing0.1μM5-ATR–ParMwithincreasingconcentrations
ofGDPinastopped-ﬂowapparatus.MicromolarGDPconcentrationsareindicatedintheFigure.
All concentrations are those in the mixing chamber. Fluorescence was excited at 546nm and
emissionwasdetectedaftera570nmlong-passﬁlter.Datawereanalysedbysingleexponential
curveﬁttingyieldingtheobservedrateconstantkobs.(B)Plotofkobs againstGDPconcentration
for5-ATR–(opencircles)and6-ATR–(closedcircles)ParM.Association(kon)anddissociation
(koff) rate constants were obtained from linear regression analysis. For 5-ATR–ParM, kon is
0.047μM−1 ·s−1 and koff is 4.8s−1; for 6-ATR–ParM, kon is 0.029μM−1 ·s−1 and koff is
3.2 s−1. Experiments were performed in 30mM Tris/HCl (pH7.5), 25mM KCl, 3mM MgCl2
and 5μM BSA at 20◦C.
AtitrationofGDPwith5-ATR–ParM,measuringﬂuorescence,
showed that this nucleotide binds only slightly weaker than ADP
(2.5-fold) (Table 1). The dissociation constant was determined
as 75 μM in a buffer containing 25 mM KCl. The GDP afﬁnity
is approximately 2-fold higher at 150 mM KCl. The biosensor
strongly discriminates between GDP and GTP (Figure 1). GTP
bindsmuchweakerthanGDPandshowsonlyasmallﬂuorescence
increase. The sensitivity of ATR–ParM is more than 100-fold
higher for GDP than for GTP; whereas 10 μM GDP causes a >2-
fold change in ﬂuorescence, >1 mM GTP is needed to produce
the same change (Figure 1). These data suggest that 5-ATR–
ParM is well suited for sensing GDP in the presence of GTP. At
nucleotideconcentrationshigherthanthoseshowninFigure2,the
ﬂuorescence decreases after reaching a maximum. However, this
is outside the concentration range of possible GDP measurements
due to saturation of the biosensor and therefore does not affect
the biosensor performance.
ATR–ParM also responds to other nucleoside diphosphates
(dADP, dGDP, CDP, dCDP, TDP and UDP) with a ﬂuorescence
increase upon binding that ranges between 9-fold and 14-fold
(Table 1). Except for CDP and dCDP, which bind considerably
weaker (Kd>700 μM), the dissociation constants of the other
nucleotidesareinthesamerangeasGDPandADP(28–105 μM).
In order to assess whether the biosensor is suitable for
real-time monitoring of GDP formation, the kinetics of GDP
binding were determined using stopped-ﬂow (Figure 2). Binding
kinetics were measured under pseudo-ﬁrst-order conditions with
excess GDP over 5-ATR–ParM. Time courses show that GDP
bindingisfast,completedin<1 sevenatthelowestconcentration
of GDP (Figure 2A). The ﬂuorescence traces are well described
by single exponentials. The observed rate constants show a linear
dependence on the concentration of GDP, indicating that the
speed of the ﬂuorescence response in the concentration range
measured is controlled by the bimolecular binding step rather
than a conformational change (Figure 2B). Association (kon)a n d
dissociation (koff) rate constants obtained from linear regression
were 0.047 μM
−1 ·s
−1 and 4.8 s
−1 respectively. The slightly
lower afﬁnity of the biosensor for GDP in comparison with ADP
[12]wasmainlyduetoalowerkon value,whereasthekoff valuewas
very similar. The dissociation constant obtained from the kinetics
(Kd =koff/kon)was103 μM,whichisinreasonableagreementwith
the value from equilibrium titrations. Given that the ﬂuorescence
response of the biosensor to GDP occurs with rate constant
koff +kon[GDP], this response is always greater than koff (4.8 s
−1).
This corresponded to a response time of <200 ms (1/koff). Thus
thebiosensoriswellsuitedforreal-timemeasurementsofGDPin
steady-stateorslowtransientkineticassaysusingmanualmixing.
In order to observe ‘pure’ GDP release rate constants using fast
kinetic techniques (e.g. stopped-ﬂow), this rate constant needs to
be ∼10-fold slower than the biosensor response, corresponding
to release rate constants of <0.5 s
−1.
The performance of the GDP biosensor was tested in real-
time assays by measuring the steady-state GTPase activity
of hGBP5. hGBP5 is a mammalian dynamin-related GTPase
that is induced by interferons, shows tumour-associated
expression and has a role in innate immunity [3,30].
GTP hydrolysis by hGBP5 was measured at different GTP
concentrationsbymonitoringGDPformationusing5-ATR–ParM
(Figure 3). To calibrate the ﬂuorescence response, 5-ATR-
ParM was titrated with GDP in the presence of different
concentrations of GTP under the assay conditions (Figure 3A).
The ﬂuorescence response was linearly dependent on GDP up
to ∼20 μM. The presence of GTP had only a small effect on
the slope of the calibration: <10% difference was observed
between 0 and 1 mM GTP. The calibration accounted for this
as described in the Experimental section. Fluorescence time
courses were converted into GDP concentrations and initial
rates were determined by linear regression (Figure 3B, inset).
Michaelis–MentenplotsofinitialratesagainstGTPconcentration
gave the parameters KM =79 μMa n dVmax =0.467 μM·min
−1
(Figure 3B). The catalytic activity (kcat)o f2 . 1m i n
−1, determined
here, was in good agreement with a previous study, where the
activity of hGBP5 was determined as 1.7 min
−1 in an HPLC-
based assay under very similar solution conditions [20].
A second application of the GDP biosensor is nucleotide
exchange of the small GTPase Ras, a key signalling molecule
in the regulation of cell growth, proliferation, differentiation and
apoptosis [31]. Ras is activated by GEFs (guanine-nucleotide-
exchange factors) that convert GDP-bound Ras into GTP-bound
Ras by accelerating nucleotide dissociation. Sos is one of
these Ras-speciﬁc exchange factors. Nucleotide exchange from
Ras–GDP to Ras–GTP was measured using 5-ATR–ParM to
monitor released GDP (Figure 4). A large excess of free GTP
over Ras–GDP was used to get complete exchange of GTP for
GDP, ensuring quasi-irreversible dissociation of GDP. GDP
release from 10 μM Ras–GDP was very slow in the absence of
nucleotide-exchange factor and strongly accelerated by addition
of the catalytic domain of Sos (Sos
cat) (Figure 4A). If there was
no GTP present to replace the dissociating GDP, a net release
of GDP was not detectable. (Figure 4A). This ﬁnding indicates
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Figure 3 Assay of the GTPase activity of hGBP5
(A) Calibration of the ﬂuorescence signal of the biosensor. 5-ATR-ParM (0.25μM) was titrated
with GDP in the absence of GTP (), with 0.5mM GTP () or with 1 mM GTP (), and
ﬂuorescenceemissionwasmonitoredasdescribedinFigure1.Theslopesfromlinearregression
analysis are 6.3μM−1,6 . 1μM−1 and 5.8μM−1 at 0, 0.5 and 1mM GTP respectively. (B)
Kinetics of GTP hydrolysis catalysed by hGBP5 were measured under steady-state conditions
with 0.22μM hGBP1, different concentrations of GTP and 0.25μM 5-ATR-ParM. The inset
showstimecoursesofGDPformationat0,10,20,35,50,100,150,200and1000μMGTP.Initial
rates were determined by linear ﬁts to data points below 10% turnover and are plotted against
GTPconcentration.AhyperboliccurveﬁtyieldstheMichaelis–MentenparametersKM =79μM
and Vmax =0.467μM·min−1. Measurements were performed in 50mM Tris/HCl (pH8.0),
25 mM KCl, 5mM MgCl2, 2 mM DTT and 5μM BSA at 25◦C.
that Sos alone cannot displace GDP from Ras. In other words,
the nucleotide-free complex of Ras and exchange factor (Sos–
Ras) is not formed in signiﬁcant amounts (<5%) under these
conditions. The apparent half-times of the exchange reaction
were 240 s, 80 s, 25 s and 2.5 s at 0.1, 0.3, 1 and 10 μMS o s
cat
respectively. Under single-turnover conditions (10 μMS o s
cat,
10 μMRas–GDP)theapparentrateconstantobtainedfromsingle
exponentialcurveﬁttingwas0.28s
−1.Thisis>10-foldfasterthan
the single-turnover rate constant reported previously at the same
concentration of Sos
cat but lower Ras–GDP (1 μM) [32,33]. The
large difference could be explained by the allosteric feedback
mechanism governing Sos-catalysed nucleotide exchange [34].
Beside the catalytic Ras binding site, Sos
cat possesses a second
interaction site, where Ras–GTP and, to a lesser extent, Ras–
GDP binding causes an allosteric activation of Sos catalytic
activity [34]. A higher concentration of Ras might lead to a
higher occupation of this allosteric site and thus faster nucleotide
exchange. In addition, the use of ﬂuorescently labelled mantGDP
in the studies of Ford et al. [32,33] might also contribute to
the observed difference in rate constants, because nucleotide
dissociation from Ras is slower for mant-nucleotides than for
unlabelled nucleotides [35].
Nucleotide exchange of the same system was measured under
steady-state conditions using a constant low concentration of
Figure 4 Sos-catalysed nucleotide exchange of Ras
(A) GDP-to-GTP exchange at different concentrations of Soscat. Ras–GDP (10μM) and
5-ATR-ParM (0.25μM) were incubated in the cuvette before GDP dissociation was initiated
by the addition of 1mM GTP and/or Soscat at the concentration indicated in the Figure. The
concentration of free GDP was calculated from a calibration as in Figure 3(A). (B) GDP-to-GTP
exchangeatdifferentconcentrationsofRas–GDP.Theexperimentwasperformedasdescribedin
(A),butwithconstant25nMSoscat andvariousconcentrationsofRas–GDP.Theinsetshowstime
coursesof GDPdissociation at 0, 25, 50, 75, 100,150, 200,300 and 500μMR a s·GDP. Initial
rates were determined by linear regression and plotted against Ras–GDP concentration. The
solid line represents the hyperbolic ﬁt to the experimental data. Measurements were performed
in 20 mM Hepes (pH7.4), 150mM KCl, 5 mM MgCl2, 2mM DTT and 5μM BSA at 25◦C.
Sos
cat and increasing concentrations of Ras–GDP (Figure 4B).
The initial rate of GDP dissociation increased with Ras–
GDP concentration with approximately hyperbolic dependence.
Although the data do not allow an accurate determination of the
Michaelis–Menten parameters since saturation is not reached,
lower limits can be estimated for KM>400 μMa n dkcat>20 s
−1.
Such a high apparent KM value has also been observed for the
related Ras GEF, Cdc25
Mm (KM =386 μM) [36]. The intrinsic
exchange rate for Ras–GDP, determined with the GDP biosensor,
was 3.6×10
−5 s
−1 (results not shown) in agreement with
previous studies [33,36]. Thus nucleotide exchange is accelerated
by Sos
cat by more than ﬁve orders of magnitude, as found for
many GEFs of small GTPases [37].
So far, the 5-isomer of ATR–ParM has been described for its
useasabiosensorfornucleosidediphosphates,inparticularGDP.
Generally the ParM version, labelled with the 6-IATR, behaves
very similarly to 5-ATR-ParM with respect to NDP and dNDP
binding (Table 1, and Figures 2 and 3). 6-ATR–ParM shows a
similar ﬂuorescence response as 5-ATR–ParM to the different
nucleoside diphosphates, with slightly lower afﬁnity for NDPs,
including GDP, and similar binding kinetics. Hence, 6-ATR–
ParM can be used in the same way as 5-ATR–ParM to measure
nucleoside diphosphates.
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In summary, 5-ATR–ParM and 6-ATR–ParM function as
biosensors for GDP that can be used to measure rates of
GTP hydrolysis and nucleotide exchange of GTPases. This is
a wide ranging group of enzymes, including small G-proteins,
heterotrimeric G-proteins, GTPases involved in transcription and
translation, and large dynamin-related GTPases. GTP-dependent
kinases are another group of enzymes that could be studied with
these biosensors, albeit they are fewer in number than GTPases.
These kinases, for example phosphoenolpyruvate carboxykinase,
transfer the γ-phosphate of GTP on to a substrate, thereby
releasing GDP. In addition there are other metabolic enzymes
that produce GDP, such as a variety of enzymes that handle
GDP sugars, for example transferases involved in carbohydrate
biosynthetic pathways, as well as speciﬁc examples, GDP-L-
galactose phosphorylase and GDP-mannose glycosyl hydrolase.
ATR–ParM shows a fast ﬂuorescence response (<200 ms
response time) allowing real-time measurements of GDP
concentrationchangesonthetimescaleofseconds.Thebiosensor
hasmicromolarsensitivityforGDPanddiscriminateswellagainst
GTP. The dynamic range for GDP detection, estimated from the
concentrations at 10% and 90% saturation, was 5–500 μMi n
Tris buffer (pH 7.5) and 150 mM KCl. These upper and lower
limitsdependontheexactbufferconditionsandwillbeshifted,e.g
byionicstrength,pHvalueandtemperature,accordingtotheGDP
dissociation constant. The ﬂuorescence response of the biosensor
is approximately linear at concentrationswell belowtheKd value,
whereas at higher concentrations a hyperbolic equation can be
usedforcalibration.ThecontributionofGTPbindingtothesignal
isnegligible(<5%)atconcentrationsupto∼800 μM(Figure1),
but can be corrected by appropriate calibrations if high accuracy
or higher concentrations of GTP are needed. In practice, the
biosensor is able to detect down to 2 μM concentrations of GDP
in the presence of mM GTP, as demonstrated in the GTPase and
nucleotideexchangeassays(Figure3and4).Thebroadspeciﬁcity
for nucleoside diphosphates and deoxynucleoside diphosphates
enables the biosensor to be used for measuring reactions that
release other diphosphates, in addition to ADP and GDP. On
the other hand, due to the similar afﬁnities of the biosensor
for the NDPs, the presence of any other diphosphate in addition
to the one to be studied would interfere with the detection,
unless its concentration is much lower than its Kd for the
biosensor. Further engineering of the active site by site-directed
mutagenesis could potentially create new variant biosensors with
higher speciﬁcity for particular diphosphates. To our knowledge
there is only one earlier described reagentless biosensor for
GDP, consisting of a coumarin-labelled nucleoside diphosphate
kinase [38]. That biosensor is also not speciﬁc for the base
and can be used to detect all NDPs and dNDPs. However, it
does not report the absolute concentration of NDP, but the ratio
of diphosphate to triphosphate. The reason is that the ﬂuor-
escence reports not on nucleotide binding, but on the
phosphorylation state of nucleoside diphosphate kinase, which
is controlled by the NTP/NDP ratio. An antibody-based assay
has been described, aimed at high-throughput assays and using
ﬂuorescencepolarization[39].Othercommonlyusedmethodsfor
measurement in vitro of nucleotide binding and GTP hydrolysis
employ either radioactive nucleotides, HPLC analysis of labelled
or unlabelled nucleotides, or measurement of released Pi from the
GTPase. For Pi measurement, there are colorimetric assays, e.g.
Malachite Green [40,41], coupled enzyme assays, for example
using purine nucleoside phosphorylase [42,43] and phosphate
biosensors [5,44,45]. However, only the coupled enzyme
and biosensor assays can be used in a real-time format, but they
are not applicable to measuring guanine-nucleotide exchange.
The other methods require stopping the reaction at different
time points to analyse individual samples, a process that can
be laborious and time consuming, especially if long separation
protocols are required. Although assays based on absorbance
detectioncanhavecomparablesensitivitywiththeGDPbiosensor
(lowmicromolarconcentrations),radioactiveassaysaregenerally
much more sensitive, but they require special equipment and
safety precautions. A large number of ﬂuorescence-based assays
rely on ﬂuorescently labelled nucleotides, for example [36,46–
48], and there are also studies where labelled GTPases or
regulatory proteins are used, for example [49,50]. These methods
are sensitive (possibly down to tens of nanomolar) and are
particularly useful for transient kinetic studies. However, one
drawback is that they require modiﬁcation of the natural
nucleotide or protein, and thus potentially disturb the system
under study. In addition, these assays are not truly generic and,
in particular with labelled GTPases, an assay has to be developed
for each GTPase.
In conclusion, the biosensor for GDP described in the present
study provides a novel generic method to measure hydrolysis
activity and guanine-nucleotide exchange of GTPases, or
the activity of GTP-dependent kinases. This method can be used
for functional and mechanistic studies on such systems, but may
also ﬁnd application in high-throughput screening of inhibitors
for this important protein class.
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Figure S1 Structure of 5-IATR and the substitution reaction
(A) Structure of 5-IATR. (B) Iodoacetamide reaction with thiol-groups of proteins (present in
cysteine residues) to form a thioether [1].
FigureS2 Analysisofdifferent5-IATR-labelledParMconstructsusingESI–
MS
Mass spectra of ParM (His6/K33A/T174A/T175N/C287A) with the additional mutations
D63C/D224C (A), D63A/D224C (B), D63C/D224A (C) and D63A/D224A (D) after a reaction
with 5-IATR. The spectra each show one main peak which indicates the labelling stoichiometry
for the different mutants (Table S1). There are also peaks with much lower intensity, some of
them corresponding to masses due to more or fewer rhodamines attached, as indicated on the
spectra.Themasschangeduetoeachrhodamineis441Da.Thesespectraindicatealowextent
of labelling amino acids other than the exposed cysteine residues.
1 To whom correspondence should be addressed (email mwebb@nimr.mrc.ac.uk).
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Figure S3 Absorbance spectra of different ParM constructs labelled with
5-IATR
The spectra are scaled so they have identical absorbance at 280nm to illustrate approximately
the different content of rhodamine labels, indicated by the absorbance in the visible range.
Tetramethylrhodaminehastwoabsorbancepeaksinthevisiblerange,whosemaximaarearound
520 and 550nm. Their relative height depends on the stacking interaction of the rhodamines
[2–4]. Although the shapes of the spectra of the D63A D224C and D63A D224A mutants
indicate that the rhodamine does not stack with a second ﬂuorophore, the spectra of D63C
D224C suggest that the attached rhodamines form a stacking interaction (as expected for this
doubly labelled species). Because of the large absorbance of rhodamine at 280nm and the
strong dependence of the spectra on rhodamine stacking and interaction with the protein, the
ratio of label to protein cannot be calculated from the absorbance spectrum with high accuracy,
especially for the doubly rhodamine labelled mutant. However, an estimate of 4% labelling
can be calculated for the D63A D224A mutant, using the molar absorption coefﬁcient of small
thiol adducts of 5-IATR (ε528 =52000 M−1 ·cm−1 [5] and ε280 =0.6×ε528) and the molar
absorption coefﬁcient of ParM (ε280 =34380 M−1 ·cm−1).
Table S1 Labelling stoichiometry of different ParM constructs as determined by MS (Figure S2)
Differences between the contructs are indicated in bold.
ParM construct Number of 5-IATR labels Theoretical mass (Da) Measured mass (Da)
(A) K33A D63C T174A T175A D224C C287A 2 37699.5 37699.8
(B) K33A D63A T174A T175A D224C C287A 1 37226.5 37226.2
(C) K33A D63C T174A T175A D224A C287A 1 37226.5 37225.6
(D) K33A D63A T174A T175A D224A C287A 0 36753.4 36752.7
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